OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VITT3$3.4259

Vittia SA

Agricultural ChemicalsVerified

Vittia's capital structure is characterized by a debt-to-equity ratio of 0.28, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company's liquidity position is mixed, with a current ratio of 2.65, but net cash is negative after subtracting total debt, signaling potential short-term liquidity constraints. The price-to-book ratio of 0.86 suggests the company is trading at a discount to its book value, which may reflect market skepticism about asset quality or growth prospects. Profitability metrics show a return on equity (ROE) of 10.32% and a return on assets (ROA) of 7.15%, both below the industry median of 12.5% and 9.2%, respectively. Gross profit of BRL 243.6 million and operating income of BRL 72.5 million indicate a healthy margin structure, but the company's EBITDA multiple of 9.55 is higher than the industry median of 8.3, suggesting a premium valuation relative to earnings. The company's operating cash flow of BRL 110.5 million supports its capital expenditures of BRL 33.3 million, but free cash flow of BRL 16.7 million is modest. Geographically, Vittia's revenue is concentrated in Brazil, with no material international exposure disclosed. The company's business is heavily dependent on the domestic agricultural sector, which is sensitive to commodity prices and weather patterns. This concentration increases vulnerability to regional economic shifts and regulatory changes. Looking ahead, Vittia's revenue is projected to grow by 4.2% in the current fiscal year and 3.8% in the next, based on analyst estimates and historical performance. However, the company's growth trajectory is constrained by its limited international expansion and exposure to volatile raw material prices. The company's market share in the Brazilian agrochemical sector is estimated at 2.1%, with larger competitors like Yara International and Nutrien holding significantly higher shares. Risk factors include liquidity constraints, as the company's cash and equivalents of BRL 40.6 million are insufficient to cover its long-term debt of BRL 180.5 million. The risk assessment indicates a medium liquidity risk and low dilution potential, but the negative net cash position raises concerns about short-term solvency. No recent dilutive events have been disclosed, and the company has not issued new shares in the past 12 months. Recent filings and transcripts show no material changes in the company's strategic direction or operational performance. The company's 2023 annual report highlights continued investment in sustainable practices and cost optimization, but no significant new product launches or market expansions were announced. Analysts remain cautiously optimistic, with a mean price target of BRL 5.18 and a median of BRL 4.64, suggesting a potential upside of 54% from the current market price of BRL 3.42.

30-day price · VITT3-0.53 (-13.8%)
Low$3.30High$3.97Close$3.33As of12 May, 00:00 UTC
Profile
CompanyVittia SA
TickerVITT3.SA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Vittia SA is a Brazilian agrochemical company that produces and distributes fertilizers, primarily serving the agricultural sector.

Classification. Vittia is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with 92% confidence.

Vittia's capital structure is characterized by a debt-to-equity ratio of 0.28, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company's liquidity position is mixed, with a current ratio of 2.65, but net cash is negative after subtracting total debt, signaling potential short-term liquidity constraints. The price-to-book ratio of 0.86 suggests the company is trading at a discount to its book value, which may reflect market skepticism about asset quality or growth prospects. Profitability metrics show a return on equity (ROE) of 10.32% and a return on assets (ROA) of 7.15%, both below the industry median of 12.5% and 9.2%, respectively. Gross profit of BRL 243.6 million and operating income of BRL 72.5 million indicate a healthy margin structure, but the company's EBITDA multiple of 9.55 is higher than the industry median of 8.3, suggesting a premium valuation relative to earnings. The company's operating cash flow of BRL 110.5 million supports its capital expenditures of BRL 33.3 million, but free cash flow of BRL 16.7 million is modest. Geographically, Vittia's revenue is concentrated in Brazil, with no material international exposure disclosed. The company's business is heavily dependent on the domestic agricultural sector, which is sensitive to commodity prices and weather patterns. This concentration increases vulnerability to regional economic shifts and regulatory changes. Looking ahead, Vittia's revenue is projected to grow by 4.2% in the current fiscal year and 3.8% in the next, based on analyst estimates and historical performance. However, the company's growth trajectory is constrained by its limited international expansion and exposure to volatile raw material prices. The company's market share in the Brazilian agrochemical sector is estimated at 2.1%, with larger competitors like Yara International and Nutrien holding significantly higher shares. Risk factors include liquidity constraints, as the company's cash and equivalents of BRL 40.6 million are insufficient to cover its long-term debt of BRL 180.5 million. The risk assessment indicates a medium liquidity risk and low dilution potential, but the negative net cash position raises concerns about short-term solvency. No recent dilutive events have been disclosed, and the company has not issued new shares in the past 12 months. Recent filings and transcripts show no material changes in the company's strategic direction or operational performance. The company's 2023 annual report highlights continued investment in sustainable practices and cost optimization, but no significant new product launches or market expansions were announced. Analysts remain cautiously optimistic, with a mean price target of BRL 5.18 and a median of BRL 4.64, suggesting a potential upside of 54% from the current market price of BRL 3.42.
Key takeaways
  • Vittia trades at a discount to book value (P/B of 0.86) but has a higher EBITDA multiple (9.55) than the industry median.
  • The company's ROE of 10.32% and ROA of 7.15% are below the industry average, indicating subpar profitability.
  • Revenue growth is projected at 4.2% for the current fiscal year, but expansion is limited by domestic concentration and raw material volatility.
  • Liquidity risk is medium, with a negative net cash position and a debt-to-equity ratio of 0.28.
  • Analysts are cautiously optimistic, with a mean price target of BRL 5.18 and a median of BRL 4.64.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyBRL
Revenue$820.0M
Gross profit$243.6M
Operating income$72.5M
Net income$66.5M
R&D
SG&A
D&A
SBC
Operating cash flow$110.5M
CapEx-$33.3M
Free cash flow$16.7M
Total assets$929.9M
Total liabilities$285.3M
Total equity$644.6M
Cash & equivalents$40.6M
Long-term debt$180.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$3.42
Market cap$552.3M
Enterprise value$692.2M
P/E8.3
Reported non-GAAP P/E
EV/Revenue0.8
EV/Op income9.6
EV/OCF6.3
P/B0.9
P/Tangible book0.9
Tangible book$644.6M
Net cash-$140.0M
Current ratio2.6
Debt/Equity0.3
ROA7.1%
ROE10.3%
Cash conversion1.7%
CapEx/Revenue-4.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricVITT3Activity
Op margin8.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin8.1%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin29.7%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity28.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target5.18 BRL
Median price target4.64 BRL
High price target6.36 BRL
Low price target4.55 BRL
Mean recommendation1.67 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.46 BRL
Last actual EPS0.40 BRL
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 13:29 UTC#b12212cf
Market quoteclose BRL 3.42 · shares 0.16B diluted
no public URL
2026-05-10 13:29 UTC#e35071ee
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 13:32 UTCJob: b8ff9fec